Results 181 to 190 of about 2,248,102 (350)

VTX: real-time high-performance molecular structure and dynamics visualization software. [PDF]

Bioinformatics
Maria M, Guionnière S, Dacquay N, Plateau-Holleville C, Guillaume V, Larroque V, Lardé J, Naimi Y, Piquemal JP, Levieux G, Lagarde N, Mérillou S, Montes M.   +12 more
europepmc   +1 more source

An Efficient Real-Time Terrain Rendering Algorithm

, 2011
Ronghua Zhang
openalex   +1 more source

KiloNeuS: A Versatile Neural Implicit Surface Representation for Real-Time Rendering

, 2022
Stefano Esposito, Daniele Baieri, Stefan Zellmann, André Hinkenjann, Emanuele Rodolà   +4 more
openalex   +2 more sources

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Phenotype hospital, physician, and emergency department (ED) visits by diagnoses and specialty up to 29 years pre‐multiple sclerosis (MS) onset versus a matched population without MS. Methods We identified people with MS (PwMS) using population‐based administrative data from Ontario, Canada (1991–2020).
Helen Tremlett, Karl Everett, Colleen J. Maxwell, Feng Zhu, Ayesha Asaf, Ping Li, Kyla A. McKay, Yinshan Zhao, Ruth Ann Marrie   +8 more
wiley   +1 more source

From Physically Based to Generative Models: A Survey on Underwater Image Synthesis Techniques. [PDF]

J Imaging
Barbosa LA, Apolinario AL.
europepmc   +1 more source

Design and evaluation of methods to prevent frame cancellation in real-time stereoscopic rendering

, 2011
Jérôme Ardouin, Anatole Lécuyer, Maud Marchal, Éric Marchand   +3 more
openalex   +2 more sources

Analysis of Game Engine Based Real-Time Rendering Methods

, 2022
Gumyoung Kim
openalex   +2 more sources

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

REAL-TIME TERRAIN RENDERING WITH INCREMENTAL LOADING FOR INTERACTIVE TERRAIN MODELLING

, 2011
Simon van den Hurk, Wallace Yuen, Burkhard C. Wünsche   +2 more
openalex   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source